Notice: Undefined variable: fileR in
/me/beta.myiris.com/htdocs/newsCentre/bin/addLinksNew.php on line
17
Notice: Undefined variable: fileR in
/me/beta.myiris.com/htdocs/newsCentre/bin/addLinksNew.php on line
142
Motilal Oswal Retail Research has recommended two stock trading ideas in its research report. Following are the stocks:
1. Indian Railways Catering and Tourism Corporation (IRCTC) - Buy
CMP - 2,015
Stop-loss -1,950
Target price - Rs 2,150
Duration -2-3 days
"IRCTC is showing tremendous strength from last few days and moved to new all-time high. It is sustaining well above its trendline breakout levels and came out of its consolidation phase of last four trading sessions. RSI oscillator is placed positively on both daily and weekly scale, indicating strength in the counter. Considering current chart structure, we advise traders to buy the stock for an up move towards 2,150 with stop-loss of 1,950."
2. SBI Life Insurance Company - Buy
CMP - 929
Target price -1,050
Upside -13%
"SBILIFE posted a strong rebound of ~53% YoY (-4% YoY in FY21 YTD) in Individual weighted received premium (WRP) in Feb'21 after showing muted trends for many months. Total un-weighted premium grew 61.8% YoY (+16.8% YoY in FY21 YTD). During FY21 YTD, SBILIFE (14% market share) remained the largest Private Insurer in terms of Individual WRP. After reporting robust growth in the Protection business over 1HFY21, the pace of growth has moderated over the past few months. However, the trend still remains healthy. SBILIFE reported a 29% growth in sum assured as compared to a 52% growth in total un-weighted Individual non-single premium. We expect premium growth to rebound over FY22 after seeing tepid trends, with ULIP showing a revival. Players continue to focus strongly on Non-PAR and Protection segments. SBILIFE remains our preferred pick."
Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.
